yep, looks like the same P3 failure that took it down from $20's to $2's Otonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX™ in Patients with Ménière's Disease https://ih.advfn.com/p.php?pid=nmona&article=76049761 Why Otonomy Shares Are Getting Absolutely Crushed https://finance.yahoo.com/news/why-otonomy-shares-getting-absolutely-124012451.html Otonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière's Disease https://finance.yahoo.com/news/otonomy-reports-results-averts-1-110000876.html https://finviz.com/quote.ashx?t=OTIC